#384 Updates in Chronic Kidney Disease with Dr. Joel Topf
The Curbsiders Internal Medicine Podcast
00:00
The Benefits of SGLT2 Inhibitors in the Treatment of CKD
AKI is a potential risk with the use of SGLT2 inhibitors, but the risk is lower when taken with DAPA CKD./nThe timing for starting a new ACE inhibitor for getting a metabolic panel is usually two to four weeks.
Play episode from 23:32
Transcript
